ENDONOVO THERAPEUTICS, INC. Insider Trading for April 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDONOVO THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENDONOVO THERAPEUTICS, INC. for April 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 30 | 21,158,123 | 21.2 M to 21.2 M (+0.01 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 32 | 21,156,123 | 21.2 M to 21.2 M (+0.01 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 32 | 21,154,123 | 21.2 M to 21.2 M (+0.01 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 74 | 21,152,123 | 21.1 M to 21.2 M (+0.02 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 31 | 21,147,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 148 | 21,145,123 | 21.1 M to 21.1 M (+0.05 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 147 | 21,135,123 | 21.1 M to 21.1 M (+0.05 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 74 | 21,125,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 30 | 21,120,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,116,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,111,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,109,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,104,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,099,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,094,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,089,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,087,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 62 | 21,085,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 25 | 21,080,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 61 | 21,078,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 117 | 21,073,123 | 21.1 M to 21.1 M (+0.05 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,063,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Sell | P | 0.01 | 2,000 | 27 | 21,061,123 | 21.1 M to 21.1 M (-0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,063,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,061,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,059,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,057,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 26 | 21,055,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 26 | 21,053,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 26 | 21,051,123 | 21 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 26 | 21,049,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 29 | 21,047,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 29 | 21,045,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 29 | 21,043,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 12,000 | 167 | 21,041,123 | 21 M to 21 M (+0.06 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 32 | 21,029,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 160 | 21,027,123 | 21 M to 21 M (+0.05 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 33 | 21,017,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 34 | 21,015,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 35 | 21,013,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 34 | 21,011,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 85 | 21,009,123 | 21 M to 21 M (+0.02 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 34 | 21,004,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 9 | 21,002,123 | 21 M to 21 M (0.00 %) |
Apr 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 85 | 26,788,897 | 26.8 M to 26.8 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 87 | 22,001,623 | 22 M to 22 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,996,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,995,623 | 22 M to 22 M (+0.01 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 18 | 21,993,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,992,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 87 | 21,991,623 | 22 M to 22 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 87 | 21,986,623 | 22 M to 22 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 87 | 21,981,623 | 22 M to 22 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,976,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,975,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 36 | 21,974,623 | 22 M to 22 M (+0.01 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,972,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 36 | 21,971,623 | 22 M to 22 M (+0.01 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 36 | 21,969,623 | 22 M to 22 M (+0.01 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,967,623 | 22 M to 22 M (+0.01 %) |